- $16.13m
- $9.90m
- $28.51m
Brief: Bionano Genomics Q4 revenue USD 8.2 million
Brief: Bionano Genomics Reports Fourth Quarter And Full-Year 2022 Results And Provides Revenue Outlook For 2023
Bionano Genomics Inc expected to post a loss of 11 cents a share - Earnings Preview
Bionano Genomics Inc expected to post a loss of 11 cents a share - Earnings Preview
Brief: Bionano Informs On China NMPA Approval
Brief: Bionano Announces Launch Of Next-Generation Versions Of Its Reagent Kits And Chip Consumable, Along With Updates To Its Instrument Control And Bionano Access Software
Brief: Bionano Announces Publication Of Interim Readout From Trial Analyzing Optical Genome Mapping As Potential Standard Of Care For Prenatal Testing
Brief: Bionano with NVIDIA To Accelerate Data Processing Solution For Optical Genome Mapping Workflow
Brief: Bionano Genomics Reports Q4 Revenue Of $7.9 Mln
U.S. RESEARCH ROUNDUP- Apollo Global Management, Microsoft, ServiceNow
Brief: Multi-Center Research Study Illustrates How OGM Can Potentially Result In More Patients Qualifying For Treatments In Leukemia
Brief: Bionano Genomics To Acquire Purigen Biosystems
Bionano Genomics Inc reports results for the quarter ended in September - Earnings Summary
Bionano Genomics Inc expected to post a loss of 11 cents a share - Earnings Preview
Brief: Bionano Genomics Announces Extensive Lineup Of Content At Association For Molecular Pathology Annual Meeting
Brief: Bionano Laboratories To Provide Enhanced Genetic Counseling And Patient Care For Genetic Disorders With Optrahealth's Healthfax™
Brief: Bionano Genomics Announces Launch Of CLIA-Certified Bionano Laboratories
Brief: Bionano Genomics Announces Publication Of Study Using OGM For Detection Of Balanced Chromosomal Rearrangements Found In Recurrent Pregnancy Loss
Brief: Bionano Genomics Announces Study Demonstrating Utility Of OGM For Quality Evaluation Of Human Induced Pluripotent Stem Cells (IPSCS)